Posts

August Is National Hair Loss Awareness Month

August Is National Hair Loss Awareness Month

/in /by

August Is National Hair Loss Awareness Month

According to the American Hair Loss Association (AHLA), an estimated 50 million men experience some level of hair loss and approximately 35 million women are also affected by thinning hair. To help those who are suffering from this condition, National Hair Loss Awareness Month (NHLAM) delivers attention to detection, prevention, and treatment of these unfortunate yet oftentimes reversible statistics.

Dr. Alan J. Bauman Reveals Bulletproof Founder Dave Asprey’s “Upgraded Hair” After His Bulletproof Radio Podcast on Biohacking Baldness

World-Renowned Hair Restoration Surgeon Dr Alan J Bauman Announces New Technologies to Detect Prevent Treat Hair Loss

The medical community also continues to see a correlation between COVID-19 and hair loss. The past 18 months have delivered unimaginable stressors and challenges. Excessive or prolonged psychological and physiological stress including fever-related illnesses can trigger heavy shedding (telogen effluvium) and accelerate hair loss.

Even those not physically infected with COVID can experience the detrimental effects of the Pandemic on their hair, scalp, and other organs. More than a quarter of patients recovering from COVID-19 have reported hair loss as one of the lingering problems from the illness.

Internationally recognized, ABHRS-Certified Hair Restoration Surgeon Dr Alan J. Bauman discusses the most efficient and effective protocols of hair loss prevention and highlights some of the newest technology in the field of hair restoration aimed at both preserving and restoring the hair.

According to Dr Bauman, who was recently named “Top Hair Restoration Surgeon of the Decade” by Aesthetic Everything®, “Early action is essential to improving the fate of the follicle. While most hair loss may be hereditary,” he states “with proper intervention, it’s also avoidable.” Because early detection and precise analysis are key to identifying the most accurate source of treatment, experts in hair restoration are celebrating the advancements in the science of hair loss detection.

ADVANCEMENTS IN DETECTION & TREATMENT

Trichotest® Genetic Hair Loss Testing performs genetic testing based on state-of-the-art DNA microarray technology to identify the exact hair loss treatments that will perform best for the patient based on DNA analysis. Trichotest® examines DNA from saliva together with details about the patients’ lifestyle and then analyzes a total of 48 genetic variations to understand specific characteristics of the metabolism which contribute to hair loss. Using proven scientifically validated global research, Trichotest® enables hair restoration experts to recommend the most successful treatment option.

HairMetrix® is the first Artificial Intelligence (AI) driven non-invasive hair measurement tool for consultations. Based on a machine-learning algorithm, the HairMetrix® system provides real-time analysis of hair density, hair calibre, and other metrics that contribute vital information to a Hair Restoration Physician and his patient by first establishing a baseline in more permanent areas of hair growth, and then comparing those measurements to weaker zones. HairMetrix® also allows for the precise tracking of hair growth results over time. Dr Bauman is one of the first physicians worldwide to use this new AI hair analysis system.

TREATING HAIR AT HOME

After a virtual or in-person consultation, at-home treatment programs include premium prescribed products such as specially formulated non-greasy highly-rated Minoxidil Formula 82M, to Formula 82F Topical Finasteride+Minoxidil and Formula 82D Topical Dutasteride+Minoxidil to the powerful FDA-cleared Bauman TURBO LaserCap Low-Level Laser Therapy device for hair regrowth, to bespoke Nutritional Supplements, and DHT-Control hair care products.

IN-OFFICE REGENERATIVE TREATMENTS

If at-home treatments don’t suffice, there are a plethora of in-office regenerative medicine treatments including PRP Platelet Rich Plasma, PDOgro™, Exosome Therapy, and other cell therapy interventions.

HAIR TRANSPLANTS

If an assessment confirms that hair follicles are dead and gone, a transplant is needed. Today’s state-of-the-art hair transplant technology includes the no-linear-scar, minimally-invasive FUE hair transplant surgery as well as the No-Shave Long-Hair Preview VIP|FUE™, a groundbreaking, minimally invasive hair transplant procedure. VIP|FUE™ delivers all the hair restoration benefits of traditional FUE without any shaving or trimming of hair.

Dr Bauman recently revealed Bulletproof Founder Dave Asprey’s “upgraded hair” at Asprey’s Virtual Biohacking Conference. Asprey, considered the “Father of Biohacking”, was at Bauman Medical last year for a 4,087 graft FUE hair transplant procedure, which also included PRP Platelet Rich Plasma with Extracellular Matrix, and followed up with at-home hair regrowth treatments using Dr Bauman’s FDA-cleared TURBO LaserCap. Asprey’s keen social media followers had already noticed “something different” about his hair and were amazed at his results. Dr Bauman will be a featured presenter discussing “Biohacking Baldness” at the upcoming in-person Upgrade 7th Annual Biohacking Conference in Orlando September 17-19.

To learn more about the newest advancements in hair restoration, please visit www.baumanmedical.com. For media interviews, please contact danna@canpublicity.com

About Alan J. Bauman, MD, ABHRS

Alan J. Bauman, MD, ABHRS is a full-time board-certified Hair Restoration Physician who has treated nearly 30,000 patients and performed over 10,000 hair transplant procedures since starting his medical hair loss practise, Bauman Medical, in 1997 in Boca Raton, FL.

Dr Bauman is one of approximately only 200 physicians worldwide to achieve certification from the esteemed American Board of Hair Restoration Surgery (ABHRS), become an accepted member of the International Alliance of Hair Restoration Surgeons (IAHRS), and also be recommended by the American Hair Loss Association. Dr Bauman has achieved the coveted Fellow status within the International Society of Hair Restoration Surgery (ISHRS), is a frequently invited faculty member at numerous international scientific meetings and live surgery workshops, and has published numerous articles and textbook chapters in the field of hair restoration and hair transplantation.

Dr Bauman has consistently been shortlisted for numerous Top Hair Transplant Surgeon recognitions and awards worldwide. He has been named “#1 Top Hair Restoration Surgeon” in North America by Aesthetic Everything for five years running and recently named by Forbes as one of “Ten CEOs Transforming Healthcare in America.” As a respected global expert in hair loss and hair restoration and a pioneer of many techniques, technologies and devices in the field, he has appeared in hundreds of feature stories and live interviews in the mass media and top health podcasts. In addition to lecturing and consulting worldwide, Dr Bauman sees patients personally and operates in his nearly 12,000 square foot “Hair Hospital” in downtown Boca Raton, FL.

August Is National Hair Loss Awareness Month

Source

Recent Posts

August Is National Hair Loss Awareness Month

August Is National Hair Loss Awareness Month

/in /by

August Is National Hair Loss Awareness Month

According to the American Hair Loss Association (AHLA), an estimated 50 million men experience some level of hair loss and approximately 35 million women are also affected by thinning hair. To help those who are suffering from this condition, National Hair Loss Awareness Month (NHLAM) delivers attention to detection, prevention, and treatment of these unfortunate yet oftentimes reversible statistics.

Dr. Alan J. Bauman Reveals Bulletproof Founder Dave Asprey’s “Upgraded Hair” After His Bulletproof Radio Podcast on Biohacking Baldness

World-Renowned Hair Restoration Surgeon Dr Alan J Bauman Announces New Technologies to Detect Prevent Treat Hair Loss

The medical community also continues to see a correlation between COVID-19 and hair loss. The past 18 months have delivered unimaginable stressors and challenges. Excessive or prolonged psychological and physiological stress including fever-related illnesses can trigger heavy shedding (telogen effluvium) and accelerate hair loss.

Even those not physically infected with COVID can experience the detrimental effects of the Pandemic on their hair, scalp, and other organs. More than a quarter of patients recovering from COVID-19 have reported hair loss as one of the lingering problems from the illness.

Internationally recognized, ABHRS-Certified Hair Restoration Surgeon Dr Alan J. Bauman discusses the most efficient and effective protocols of hair loss prevention and highlights some of the newest technology in the field of hair restoration aimed at both preserving and restoring the hair.

According to Dr Bauman, who was recently named “Top Hair Restoration Surgeon of the Decade” by Aesthetic Everything®, “Early action is essential to improving the fate of the follicle. While most hair loss may be hereditary,” he states “with proper intervention, it’s also avoidable.” Because early detection and precise analysis are key to identifying the most accurate source of treatment, experts in hair restoration are celebrating the advancements in the science of hair loss detection.

ADVANCEMENTS IN DETECTION & TREATMENT

Trichotest® Genetic Hair Loss Testing performs genetic testing based on state-of-the-art DNA microarray technology to identify the exact hair loss treatments that will perform best for the patient based on DNA analysis. Trichotest® examines DNA from saliva together with details about the patients’ lifestyle and then analyzes a total of 48 genetic variations to understand specific characteristics of the metabolism which contribute to hair loss. Using proven scientifically validated global research, Trichotest® enables hair restoration experts to recommend the most successful treatment option.

HairMetrix® is the first Artificial Intelligence (AI) driven non-invasive hair measurement tool for consultations. Based on a machine-learning algorithm, the HairMetrix® system provides real-time analysis of hair density, hair calibre, and other metrics that contribute vital information to a Hair Restoration Physician and his patient by first establishing a baseline in more permanent areas of hair growth, and then comparing those measurements to weaker zones. HairMetrix® also allows for the precise tracking of hair growth results over time. Dr Bauman is one of the first physicians worldwide to use this new AI hair analysis system.

TREATING HAIR AT HOME

After a virtual or in-person consultation, at-home treatment programs include premium prescribed products such as specially formulated non-greasy highly-rated Minoxidil Formula 82M, to Formula 82F Topical Finasteride+Minoxidil and Formula 82D Topical Dutasteride+Minoxidil to the powerful FDA-cleared Bauman TURBO LaserCap Low-Level Laser Therapy device for hair regrowth, to bespoke Nutritional Supplements, and DHT-Control hair care products.

IN-OFFICE REGENERATIVE TREATMENTS

If at-home treatments don’t suffice, there are a plethora of in-office regenerative medicine treatments including PRP Platelet Rich Plasma, PDOgro™, Exosome Therapy, and other cell therapy interventions.

HAIR TRANSPLANTS

If an assessment confirms that hair follicles are dead and gone, a transplant is needed. Today’s state-of-the-art hair transplant technology includes the no-linear-scar, minimally-invasive FUE hair transplant surgery as well as the No-Shave Long-Hair Preview VIP|FUE™, a groundbreaking, minimally invasive hair transplant procedure. VIP|FUE™ delivers all the hair restoration benefits of traditional FUE without any shaving or trimming of hair.

Dr Bauman recently revealed Bulletproof Founder Dave Asprey’s “upgraded hair” at Asprey’s Virtual Biohacking Conference. Asprey, considered the “Father of Biohacking”, was at Bauman Medical last year for a 4,087 graft FUE hair transplant procedure, which also included PRP Platelet Rich Plasma with Extracellular Matrix, and followed up with at-home hair regrowth treatments using Dr Bauman’s FDA-cleared TURBO LaserCap. Asprey’s keen social media followers had already noticed “something different” about his hair and were amazed at his results. Dr Bauman will be a featured presenter discussing “Biohacking Baldness” at the upcoming in-person Upgrade 7th Annual Biohacking Conference in Orlando September 17-19.

To learn more about the newest advancements in hair restoration, please visit www.baumanmedical.com. For media interviews, please contact danna@canpublicity.com

About Alan J. Bauman, MD, ABHRS

Alan J. Bauman, MD, ABHRS is a full-time board-certified Hair Restoration Physician who has treated nearly 30,000 patients and performed over 10,000 hair transplant procedures since starting his medical hair loss practise, Bauman Medical, in 1997 in Boca Raton, FL.

Dr Bauman is one of approximately only 200 physicians worldwide to achieve certification from the esteemed American Board of Hair Restoration Surgery (ABHRS), become an accepted member of the International Alliance of Hair Restoration Surgeons (IAHRS), and also be recommended by the American Hair Loss Association. Dr Bauman has achieved the coveted Fellow status within the International Society of Hair Restoration Surgery (ISHRS), is a frequently invited faculty member at numerous international scientific meetings and live surgery workshops, and has published numerous articles and textbook chapters in the field of hair restoration and hair transplantation.

Dr Bauman has consistently been shortlisted for numerous Top Hair Transplant Surgeon recognitions and awards worldwide. He has been named “#1 Top Hair Restoration Surgeon” in North America by Aesthetic Everything for five years running and recently named by Forbes as one of “Ten CEOs Transforming Healthcare in America.” As a respected global expert in hair loss and hair restoration and a pioneer of many techniques, technologies and devices in the field, he has appeared in hundreds of feature stories and live interviews in the mass media and top health podcasts. In addition to lecturing and consulting worldwide, Dr Bauman sees patients personally and operates in his nearly 12,000 square foot “Hair Hospital” in downtown Boca Raton, FL.

August Is National Hair Loss Awareness Month

Source

Recent Posts

Hair Loss Supplement Market

Hair Loss Supplement Market

/in /by

Hair Loss Supplement Market Insights 2020, Global and Chinese Analysis and Forecast to 2024

Hair Loss Supplement Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hair Loss Supplement industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hair Loss Supplement manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry

.Overall, the report provides an in-depth insight into the 2014-2024 global and Chinese Hair Loss Supplement market covering all important parameters. The key points of the report:

1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.

2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.

3.Through the statistical analysis, the report depicts the global and Chinese total market of the Hair Loss Supplement industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.

4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

5.The report then estimates the 2019-2024 market development trends of the Hair Loss Supplement industry. Analysis of upstream raw materials, downstream demand and current market dynamics is also carried out.

6.The report makes some important proposals for a new project of the Hair Loss Supplement Industry before evaluating its feasibility. There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For the competitor segment, the report includes global key players of Hair Loss Supplement as well as some small players. At least 4 companies are included:

* Nutrafol(US)
* Komplete Balance(US)
* ArtNaturals(US)
* Lia Wellness
The information for each competitor includes:

* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For the product type segment, this report listed the main product type of the Hair Loss Supplement market global and in china.

* Tablets
* Capsules
* Others

For the end use/application segment, this report focuses on the status and outlook for key applications. End users are also listed.

* Individuals
* Clinics
* Others

Reasons to Purchase this Report:

* Estimates 2019-2024 Hair Loss Supplement market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format. Any special requirements about this report, please let us know and we can provide a custom report.

Hair Loss Supplement Market Insights 2020, Global and Chinese Analysis and Forecast to 2024

Source

Recent Posts

Platelet Rich Plasma and Stem Cell Alopecia

Platelet Rich Plasma and Stem Cell Alopecia

/in /by

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market

The Global Platelet Rich Plasma and Stem Cell Alopecia Treatment market exposition comprehensive information that help to build business strategists during the forecast 2021-2027.

Which provides an exhaustive analysis of key market trends & dynamics along with market estimates & forecasts covering major geographies/countries on the basis of historical data. Considering Platelet Rich Plasma and Stem Cell Alopecia Treatment revolutions of the cat1 industry which is major factors of growth.

Research Methodology

Our research methodology constitutes a mix of secondary & primary research sources which ideally starts from exhaustive data mining, conducting primary interviews (suppliers/distributors/end-users), and formulating insights, estimates, growth rates accordingly. Final primary validation is a mandate to confirm our research findings with Key Opinion Leaders (KoLs), Industry Experts, Self-Adhesive Labels includes major supplies & Independent Consultants among others.

The report used two methodologies FPNV Positioning Matrix and the Competitive Strategic Window to assess the figures for all segments and competitive marketplace in terms of product satisfaction and business strategy they follow to sustain in the market.

Pharmaceuticals and Healthcare Development

– India has reached out to top American pharma companies seeking investment in the country’s pharmaceutical and medical devices sector
– The Serum Institute of India will invest 240 million pounds in the UK
– The annual change in WPI notified by the government works out to 0.5% for 2020, the drug prices regulator National Pharmaceutical Pricing Authority said.

Market Segmentation

The Platelet Rich Plasma and Stem Cell Alopecia Treatment market is segmented on the basis of type, application, end-use industry, and region & country.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market by Type

Based on Platelet Rich Plasma and Stem Cell Alopecia Treatment type, the market is divided into type Androgenic Alopecia, Congenital Alopecia, Cicatricial Or Scarring Alopecia. Platelet Rich Plasma and Stem Cell Alopecia Treatment market’s sub-segment is expected to hold the largest market share during the forecast period. Increased demand for high-quality industrial valves in the Pharmaceuticals and Healthcare and other industries.

Also to mitigate the risk of contamination is driving the demand for Platelet Rich Plasma and Stem Cell Alopecia Treatment at present. The growing concern about the market and industry is expected to boost the Platelet Rich Plasma and Stem Cell Alopecia Treatment market in Pharmaceuticals and Healthcare.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market by Application

Based on Platelet Rich Plasma and Stem Cell Alopecia Treatment application, the market is divided into Hospital, Dermatology Clinic, Other. Platelet Rich Plasma and Stem Cell Alopecia Treatment application valves are one of the most basic and indispensable components of today’s modern technological society. A market segment is expected to hold the largest market share in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market.

Global Market Scope and Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size

The scope of the report is to provide a 360-degree view of the market by assessing the entire value chain and analyzing the key Platelet Rich Plasma and Stem Cell Alopecia Treatment market trends from 2021 to 2027 underlying in specific geographies. Qualitative and quantitative aspects are interlinked to provide rationales on market numbers, CAGR, and forecasts.

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Country Level Analysis

Most of the countries are estimated to emerge as the fastest growing region and hold the largest market share in the global industrial Platelet Rich Plasma and Stem Cell Alopecia Treatment market, mainly due to Growing industry trends of present situations, which cannot be ignored. Geographically, regional insights have been segmented on the basis of North America, Europe, Asia Pacific, South America and The Middle East And Africa region.

Key Platelet Rich Plasma and Stem Cell Alopecia Treatment market players identified in the report are listed below

Kerastem, Stemcell Technologies, Eclipse, Glofinn Oy., Regen Lab SA, Histogen, RepliCel Life Sciences

Market

Some of the other major highlights of the demand for Platelet Rich Plasma and Stem Cell Alopecia Treatment report include analysis, purchasing volume, prices, pricing analysis, and regulatory framework. Coverage on manufacturing structure, distribution channels, and Porter’s Five Forces analysis are also incorporated in the scope to provide analysis on the demand and supply side. This is anticipated to create opportunities for the growth of the Platelet Rich Plasma and Stem Cell Alopecia Treatment market during the forecast period.

COVID-19 Impact Analysis

– The COVID-19 pandemic had a significant impact on the on-trade segment and Industry.
– Manufacturers are comprehending strategies to revive from the current situation by means of reshaping their sales channels as well as product innovation.
– The duration of the virus outbreak remains a key factor in assessing the overall impact of the pandemic. However, the global Platelet Rich Plasma and Stem Cell Alopecia Treatment industry is expected to stabilize after 2021.
– The liquor industry was not impacted severely due to the pandemic.

Key Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Trends

– The report identifies, determines, and forecasts the Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
– Industry to Industry Holds Largest Share in the Platelet Rich Plasma and Stem Cell Alopecia Treatment Market
– It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
– Demand from Regional / geographical is Expected to Drive the Growth
– Rising Adoption of Market Segments in the Platelet Rich Plasma and Stem Cell Alopecia Treatment Growth
– North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
– It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Platelet

Rich Plasma and Stem Cell Alopecia Treatment Market.

Table of Contents

Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market, years considered, and study objectives. Additionally, it touches on the segmentation study provided in the report on the basis of the type of product and application.

Executive Summary: It gives a summary of key studies, market growth rate, competitive landscape, market drivers, trends, and issues, and macroscopic indicators.

Production by Region: Here, the report provides information related to import and export, production, revenue, and key players of all regional markets studied.

Profile of Manufacturers: Each player profiled in this section is studied on the basis of SWOT analysis, their products, production, value, capacity, and other vital factors.

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Growth are segmented on the basis of market type, application, end-user and region.

Based on Type

Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia

Based on Application

Hospital
Dermatology Clinic
Other

Regions Covered

Americas
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Chile
Colombia
Rest Of Latin America

Europe
United Kingdom
Germany
France
Italy
Spain
Netherlands
Sweden
Rest of Europe

Asia-Pacific
China
India
Japan
South Korea
Australia
Singapore
Indonesia
Malaysia
Thailand
Philippines,
Vietnam
Rest of Asia-Pacific

The Middle East And Africa
Saudi Arabia
United Arab Emirates
South Africa
Iran
Turkey
Morocco
Nigeria
Algeria
Cameroon
Chad
Congo
Egypt
Kuwait
Rest of LAMEA

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market

Source

Recent Posts

Gene Tied to Balding

Gene Tied to Balding

/in /by

Gene Tied to Balding May Also Raise COVID Risks for Men

It’s long been known that COVID-19 is more fatal for men than women, and new research links some of that excess risk to a gene known to cause a form of hair loss in males.

A U.S. team of researchers first suspected the link when they noticed that men with a common form of hormone-sensitive hair loss, known as androgenetic alopecia, were also more prone to being hospitalized with COVID-19.

“Among hospitalized men with COVID-19, 79% presented with androgenetic alopecia compared to 31%-53% that would be expected in a similarly aged match population,” said researchers led by Dr Andy Goren, chief medical officer at Applied Biology Inc. in Irvine, Calif. They presented their findings May 6 at the virtual spring meeting of the European Academy of Dermatology and Venereology (EADV).

The researchers noted that androgenetic alopecia is caused by the activity of the androgen receptor (AR) gene, which in some men can lead to hair loss. An enzyme called TMPRSS2, the key to COVID-19 infection, is also androgen-sensitive, and might be affected by the AR gene as well, Goren’s group explained.

One key segment on the AR gene appears to affect both COVID-19 severity and the propensity of men to lose their hair due to androgenetic alopecia.

In the new study, the Irvine group conducted a genetic analysis of 65 men hospitalized with COVID-19. They found that men with certain structural differences in the AR gene were more likely to develop severe COVID-19. Speaking in a meeting press release, Goren said the AR gene aberration “could be used as a biomarker to help identify male COVID-19 patients most at risk for ICU admissions.”

He also believes that “the identification of a biomarker connected with the androgen receptor is another piece of evidence highlighting the important role of androgens [male hormones] in COVID-19 disease severity.”

Dr. Teresa Murray Amato is chair of emergency medicine at Long Island Jewish Forest Hills in New York City and has seen many severe cases of COVID-19. She wasn’t connected to the new research, but said it “did show a significant correlation between a higher number of androgen receptors and a higher incidence of ICU admissions for patients infected with COVID-19.”

Amato added, “While the study is small and the exact association is not completely understood, it may show at least one answer to why men were more likely to be admitted to ICU and have overall higher morality with COVID-19 infections.”

According to Amato, more research is needed to determine whether “medications that block androgen receptors will be useful in treating a subset of [COVID-19] patients.”

Because the findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

Gene Tied to Balding May Also Raise COVID Risks for Men

Source

Recent Posts

MicroRNA That Shows Promise for Hair Regrowth

MicroRNA That Shows Promise for Hair Regrowth

/in /by

Researchers Identify MicroRNA That Shows Promise for Hair Regrowth

Researchers from North Carolina State University have identified a microRNA (miRNA) that could promote hair regeneration. This miRNA – miR-218-5p – plays an important role in regulating the pathway involved in follicle regeneration and could be a candidate for future drug development.

Hair growth depends on the health of dermal papillae (DP) cells, which regulate the hair follicle growth cycle. Current treatments for hair loss can be costly and ineffective, ranging from invasive surgery to chemical treatments that don’t produce the desired result.

Recent hair loss research indicates that hair follicles don’t disappear where balding occurs, they just shrink. If DP cells could be replenished at those sites, the thinking goes, then the follicles might recover.

A research team led by Ke Cheng, Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine at NC State’s College of Veterinary Medicine and professor in the NC State/UNC Joint Department of Biomedical Engineering, cultured DP cells both alone (2D) and in a 3D spheroid environment. A spheroid is a three-dimensional cellular structure that effectively recreates a cell’s natural microenvironment.

In a mouse model of hair regeneration, Cheng looked at how quickly hair regrew on mice treated with 2D cultured DP cells, 3D spheroid-cultured DP cells in a keratin scaffolding, and the commercial hair loss treatment Minoxidil. In a 20-day trial, mice treated with the 3D DP cells had regained 90% of hair coverage at 15 days.

“The 3D cells in a keratin scaffold performed best, as the spheroid mimics the hair microenvironment and the keratin scaffold acts as an anchor to keep them at the site where they are needed,” Cheng says. “But we were also interested in how DP cells regulate the follicle growth process, so we looked at the exosomes, specifically, exosomal miRNAs from that microenvironment.” Exosomes are tiny sacs secreted by cells that play an important role in cell to cell communication. Those sacs contain miRNAs.

MiRNAs are small molecules that regulate gene expression. Cheng and his team measured miRNAs in exosomes derived from both 3D and 2D DP cells. In the 3D DP cell-derived exosomes, they pinpointed miR-218-5p, a miRNA that enhances the molecular pathway responsible for promoting hair follicle growth. They found that increasing miR-218-5p promoted hair follicle growth, while inhibiting it caused the follicles to lose function.

“Cell therapy with the 3D cells could be an effective treatment for baldness, but you have to grow, expand, preserve and inject those cells into the area,” Cheng says. “MiRNAs, on the other hand, can be utilized in small molecule-based drugs. So potentially you could create a cream or lotion that has a similar effect with many fewer problems. Future studies will focus on using just this miRNA to promote hair growth.”

The research appears in Science Advances, and was supported by the National Institutes of Health and the American Heart Association. Cheng is corresponding author. Postdoctoral researcher Shiqi Hu is first author.

-peake-

“Dermal exosomes containing miR-218-5p promote hair regeneration by regulating β-catenin signaling”

DOI: 10.1126/sciadv.aba1685

Authors: Shiqi Hu, Zhenhua Li, Halle Lutz, Teng Su, Ke Cheng, North Carolina State University College of Veterinary Medicine and the NC State/UNC Joint Department of Biomedical Engineering; Ke Huang, Jhon Cores, Phuong-Uyen Cao Dinh, North Carolina State University College of Veterinary Medicine

Published: July 24, in Science Advances

Abstract: The progression in the hair follicle cycle from the telogen to the anagen phase is the key to regulating hair regrowth. Dermal papilla (DP) cells support hair growth and regulate the hair cycle. However, they gradually lose key inductive properties upon culture. DP cells can partially restore their capacity to promote hair regrowth after being subjected to spheroid culture. In this study, results revealed that DP spheroids are effective at inducing the progression of the hair follicle cycle from telogen to anagen compared with just DP cell or minoxidil treatment.

Because of the importance of paracrine signaling in this process, secretome and exosomes were isolated from DP cell culture, and their therapeutic efficacies were investigated. We demonstrated that miR-218-5p was notably up-regulated in DP spheroid–derived exosomes. Western blot and immunofluorescence imaging were used to demonstrate that DP spheroid–derived exosomes down-regulated the secreted frizzled-related protein 2 and up-regulated β-catenin, promoting the development of hair follicles.

Researchers Identify MicroRNA That Shows Promise for Hair Regrowth

Source

Recent Posts

Scalp Microneedling Market

Scalp Microneedling Market

/in /by

2021-2027 Global Scalp Microneedling Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

Description_

This report elaborates the market size, market characteristics, and market growth of the Scalp Microneedling industry, and breaks it down according to the type, application, and consumption area of Scalp Microneedling.

The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Scalp Microneedling in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Scalp Microneedling market covered in Chapter 13

Lotus
Yonghe Hair Transplant
zcalp

In Chapter 6, on the basis of types, the Scalp Microneedling market from 2015 to 2025 is primarily split into:

Under 0.25 mm
25mm-0.3mm
75mm-1.0mm
1.0mm-1.5mm
Above 1.5mm

In Chapter 7, on the basis of applications, the Scalp Microneedling market from 2015 to 2025 covers:

Hair Transplant
Boost Hair
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5

United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapters 8, 9, 10, 11, 12

North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)

The Middle East and Africa (Covered in Chapter 11)

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

2021-2027 Global Scalp Microneedling Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

Source

Recent Posts

Genetic Test for Hair Loss

Genetic Test for Hair Loss

/in /by

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners’ assessment and treatment of hair loss in the US: TrichoTest.*

TrichoTest is a genetic test performed on patients’ DNA that analyzes 13 genes and 48 genetic variations related to alopecia, including androgenetic alopecia, alopecia areata, and telogen effluvium. This genetic test is based on state-of-the-art DNA microarray technology and utilizes a patented algorithm to provide a personalized treatment recommendation to medical practitioners from 175 million therapeutic alternatives.

TrichoTest analyzes prostaglandins metabolism, inflammation, androgenic effect, vasodilation and blood circulation, collagen synthesis, vitamins and minerals metabolism, and insulin-like growth factor metabolism.

Introducing the most advanced genetic test supporting assessment and treatment of hair loss: TrichoTest, by Fagron.

Alopecia is a progressive and multifactorial condition related to endogenous and exogenous factors. Often, endogenous factors are genetics and are associated with gene expression. The most common type of hair loss, known as androgenetic alopecia, is hereditary. If left untreated, hair loss usually progresses over time.

TrichoTest is the most complete genetic test for alopecia, analyzing genetic factors and other relevant patient characteristics.

TrichoTest supports treatment efficacy. The test results can help medical practitioners develop a personalized treatment plan for their patients, which may include compounded topical solutions, oral supplements, and prescription hair care products.

Today, TrichoTest is the only complete genetic test for alopecia and hereditary hair loss in the US market.

About Fagron North America
Fagron North America (NA), a top-tier pharmaceutical supplier, is focused on creating the future of personalized medicine through investments in genomics, technology, pharmacy essentials and 503B outsourcing.

Fagron Inc., a Fagron NA brand, produces high-quality, innovative pharmaceutical raw materials, equipment, and supplies to prepare personalized medication in the pharmacy. Fagron Inc. offers a broad product portfolio across oral and topical compounding ingredients. As a global leader in pharmaceutical compounding, Fagron supports patient-focused medication that works to improve quality of life.

*TrichoTest is not approved by the Food and Drug Administration and is not intended to diagnose, treat, cure or prevent disease. Any recommendations given to the requesting medical practitioner are for informational purposes only and no individual is required to use any products mentioned in a report.

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

Source

Recent Posts

Nanotechnology Revolutionize Hair Loss Industry

Nanotechnology Revolutionize Hair Loss Industry

/in /by

Nanotechnology Revolutionize Hair Loss Industry

The nano hair fiber by BROOK BIOTECH supports & helps to disguise hair loss or baldness. Hair nanofiber is an acknowledged approach to effectively for hair loss. This revolutionary tool has the potential to generate much more hair for people without any side effects.

The company Brook Biotech whose CEO is the famous Brazilian banker and entrepreneur Wesley Brook, he said that is an innovative new that changes the scenario. It is a convenient and revolutionary method that allows users to have more hair and leave without any sort of embarrassment of baldness in society.

The product named Hair nano markets hits the American market in June 2021 and is now available, he said using the product is quite efficient all you need to do is to apply the product with a fixative, and that’s all.

According to him, the hair nano keratin protein, blends undetectably with existing hair strands, to instantly create the appearance of naturally thick full hair. Nanofibers produced by BROOK BIOTECH resist winds, rain, and perspiration, for long-lasting results in being conditions.

He proceeds that the product is available in every nine shades that can be mixed to match any hair color, keratin fibers also work for all hair types and textures. Also great for part lines, covering extension tracks, and touching up roots between hair color appointments which are easily washed out with shampoo.

The company stated Generally that its purpose is to bring a solution for pain and low esteem, to millions of people products are 100% guaranteed safe as they are made up of natural fiber sources and are alcohols, gluten, and paraben-free and never tested on animals.

About

The company was founded in 2020 by Brazilian Wesley Brook, a bank, Economist residing In Miami, the company reveals that it wants to act in the cosmetic segment with the focus on hair loss and have an 80% growth, in 2020 with 8-digits turnover.

Nanotechnology Revolutionize Hair Loss Industry

Source

Recent Posts

New Post for Hair Loss Restoration Options

New Post for Hair Loss Restoration Options

/in /by

SVHI PRP Therapy Announces New Post for Hair Loss Restoration Options for Bay Area Locals

SHVI PRP Therapy, a best-in-class clinic for platelet-rich plasma therapy in the Bay Area is proud to announce a new post for hair loss restoration options. Hair loss treatments focused on rejuvenating hair follicles may be the right solution for an individual. Thicker, healthier hair could inspire a person to live life to the fullest.

“It’s seldom discussed, but people with thinning hair will go out of their way to hide it. A person could dodge situations exposing their secret. For instance, staying home on windy days while their friends have fun,” explained Miguel Canales, surgeon, and founder of SVHI PRP therapy. “We are here to help with solutions, so Bay Area residents get back the confidence to enjoy life again and take on adventures.”

Bay Area residents can read the new post about hair loss restoration options by SVHI PRP. Solutions for thinning hair can include the support of cell growth by isolating blood plasma.

Many studies indicate that new, healthy plasma cells injected into the scalp can help promote thicker hair. The clinic provides alternative hair restoration treatment along with other options to help address baldness. Interested persons can find the complete list of hair transplant and treatment services on the Silicon Valley Hair Institute page. Dr Miguel Canales, a top surgeon for hair transplant and dermatology issues, welcomes Bay Area residents to reach out for a no-obligation consultation to identify the best individual hair loss restoration option.

FINDING THE BEST HAIR LOSS RESTORATION OPTIONS COULD BE A BREEZE FOR BAY AREA LOCALS

Here is the background on this release. Residents living around the San Francisco peninsula could find windy weather a typical part of Bay Area life. People might welcome cool, invigorating ocean breezes along the peninsula while enjoying weekend adventures such as hiking, biking, or sailing. Some residents could be concerned about thinning hair and avoid situations that could expose the problem to others. For these reasons, SVHI PRP Therapy announces a new post for people suffering from hair loss and possible restoration options.

ABOUT SVHI PRP THERAPY

SVHI PRP Therapy is a Bay Area company based in Foster City, California, that offers PRP for hair loss to clients from San Francisco to San Mateo, Palo Alto to Redwood City, Redwood City Burlingame, and beyond. Clients suffering from hair loss and seek innovative therapy come to SVHI PRP Therapy to explore their options, including PRP therapy for hair loss. The company offers a no-obligation consultation on hair loss with Dr Miguel Canales, a recognized specialist in the hair loss industry, including hair transplantation.

SVHI PRP Therapy Announces New Post for Hair Loss Restoration Options for Bay Area Locals

Source

Recent Posts

Stem Cell Alopecia Treatment

Stem Cell Alopecia Treatment

/in /by

Global Stem Cell Alopecia Treatment Market By Indication, By Geographic Scope And Forecast

According to Verified Market Research, The Global Stem Cell Alopecia Treatment Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.

The Global Stem Cell Alopecia Treatment Market report provides a holistic evaluation of the market for the forecast period (2017–2026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities, and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Stem Cell Alopecia Treatment Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period.

Alopecia is an autoimmune skin disease that mainly affects the hair follicles, resulting in hair loss. There are three types of alopecia namely, alopecia areata, alopecia totalis, and alopecia Universalis. Both children and adults of all age groups are capable of acquiring such disease. The stem cell is used as therapy for regenerating hair growth. This approach is minimally invasive and therefore eliminates the need for undergoing surgery. Such treatment is available in hospitals, and dermatology clinics.

Global Stem Cell Alopecia Treatment Market Outlook

In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The market is in demand as people are more concerned about facial appearance and therefore adopting such treatment. The use of such treatment options is utilized more in dermatology clinics than in hospitals. The number of clinics offering the stem-cell alopecia treatment is surging as patients are adopting the minimally invasive way for treatment. The hormonal and nutritional imbalance among adults is driving market growth. Drugs for treating alopecia is already available in the market, but it comes with adverse side effects. Therefore, the market for stem cell alopecia treatment has a future scope.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global Stem Cell Alopecia Treatment Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Stem Cell Alopecia Treatment Market Competitive Landscape

The “Global Stem Cell Alopecia Treatment Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as APEX Biologix, Belgravia Center, RepliCel, Riken Research Institute, Kerastem, Sanford Burnham Prebys Medical Discovery Institute. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Global Stem Cell Alopecia Treatment Market, By Indication

• Male Pattern Baldness
• Female Pattern Baldness
• Others

Global Stem Cell Alopecia Treatment Market Geographic Scope

• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Rest of the World

Global Stem Cell Alopecia Treatment Market By Indication, By Geographic Scope And Forecast

Source

Recent Posts

US Hair Transplant Procedure